Drug patents: innovation v. accessibility.
作者信息
Collier Roger
出版信息
CMAJ. 2013 Jun 11;185(9):E379-80. doi: 10.1503/cmaj.109-4465. Epub 2013 Apr 29.
Abstract
摘要
相似文献
1
Drug patents: innovation v. accessibility.药品专利：创新与可及性的权衡
CMAJ. 2013 Jun 11;185(9):E379-80. doi: 10.1503/cmaj.109-4465. Epub 2013 Apr 29.
2
Patents: a threat to innovation?专利：对创新的威胁？
Science. 2010 Jan 1;327(5961):31-2; author reply 32. doi: 10.1126/science.327.5961.31.
3
Drug patents: the evergreening problem.药品专利：专利期限延长问题。
CMAJ. 2013 Jun 11;185(9):E385-6. doi: 10.1503/cmaj.109-4466. Epub 2013 Apr 29.
4
Taking TRIPS to India--Novartis, patent law, and access to medicines.前往印度的《与贸易有关的知识产权协定》之行——诺华公司、专利法与药品可及性
N Engl J Med. 2007 Feb 8;356(6):541-3. doi: 10.1056/NEJMp068245.
5
India's patent laws under pressure.
Lancet. 2012 Sep 15;380(9846):e2-4. doi: 10.1016/s0140-6736(12)61513-x.
6
How Patent Troll Legislation Can Increase Timely Access to Generic Drugs.
JAMA Intern Med. 2016 Jun 1;176(6):729-30. doi: 10.1001/jamainternmed.2016.1867.
7
Court refuses to hurry generic Lipitor decision.法院拒绝仓促做出关于立普妥仿制药的决定。
Nat Rev Drug Discov. 2011 Jun;10(6):406-7. doi: 10.1038/nrd3476.
8
Intellectual property. Balancing innovation and access: patent challenges tip the scales.知识产权。平衡创新与获取：专利挑战使天平倾斜。
Science. 2009 Oct 16;326(5951):370-1. doi: 10.1126/science.1176116.
9
Intellectual property. Challenges to India's pharmaceutical patent laws.知识产权。印度制药专利法面临的挑战。
Science. 2012 Jul 27;337(6093):414-5. doi: 10.1126/science.1224892. Epub 2012 Jul 5.
10
Limiting "evergreening" for a better balance of drug innovation incentives.限制“常青化”以更好地平衡药物创新激励措施。
CMAJ. 2013 Aug 6;185(11):939. doi: 10.1503/cmaj.130992. Epub 2013 Jul 22.
Zotero 插件